The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S. Untangling the sprawling, global supply chain will be complicated and expensive, and could inadvertently compete with other administration goals regarding drug pricing and availability. The post The Myth of All-American Drugs and What Trump’s Tariffs Miss About…

Read More

States Pass Privacy Laws To Protect Brain Data Collected by Devices

More states are passing laws to protect information generated by a person’s brain and nervous system as technology improves the ability to unlock the sensitive details of a person’s health, mental states, emotions, and cognitive functioning. Colorado, California, and Montana are among the states that have recently required safeguarding brain data collected by devices outside…

Read More

6 Health Systems that Faced Worker Strikes This Month

Healthcare workers at six health systems across the country have launched strikes in July so far. These healthcare employees cite unsafe staffing levels, low wages and retaliation against union organizers as their main reasons for going on strike. The post 6 Health Systems that Faced Worker Strikes This Month appeared first on MedCity News.

Read More

Impact of NIH Funding Cuts on Drug Development

Last week, the Congressional Budget Office (CBO) released a report titled “How Changes to Funding for the NIH and Changes in the FDA’s Review Times Would Affect the Development of New Drugs.” The report evaluates two scenarios: A permanent 10 percent reduction in the amount of funding that the government provides to the NIH, andA…

Read More